0001940250-22-000001.txt : 20220728 0001940250-22-000001.hdr.sgml : 20220728 20220728164847 ACCESSION NUMBER: 0001940250-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220728 DATE AS OF CHANGE: 20220728 EFFECTIVENESS DATE: 20220728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biolog, Inc. /DE/ CENTRAL INDEX KEY: 0001940250 IRS NUMBER: 881071489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-454088 FILM NUMBER: 221115891 BUSINESS ADDRESS: STREET 1: 21124 CABOT BLVD. CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-785-2564 MAIL ADDRESS: STREET 1: 21124 CABOT BLVD. CITY: HAYWARD STATE: CA ZIP: 94545 D 1 primary_doc.xml X0708 D LIVE 0001940250 Biolog, Inc. /DE/ 21124 CABOT BLVD. HAYWARD CA CALIFORNIA 94545 510-785-2564 DELAWARE None None Corporation true 2022 Robert Wicke 21124 Cabot Blvd. Hayward CA CALIFORNIA 94545 Executive Officer Director CEO Chad Souvignier 6440 North Swan Road, Suite 200 Tucson AZ ARIZONA 85718 Director David Weber 21124 Cabot Blvd. Hayward CA CALIFORNIA 94545 Director Joseph D. Keegan 21124 Cabot Blvd. Hayward CA CALIFORNIA 94545 Director Tim Harkness 21124 Cabot Blvd. Hayward CA CALIFORNIA 94545 Director Jason Novi 21124 Cabot Blvd. Hayward CA CALIFORNIA 94545 Executive Officer CFO Bill Snider 21124 Cabot Blvd. Hayward CA CALIFORNIA 94545 Director Biotechnology Decline to Disclose 06b false 2022-04-28 false true false 1 10000000 10000000 0 This filing covers the sale and issuance of Series A Preferred Stock and the underlying Common Stock issuable upon conversion thereof. false 19 0 0 0 false Biolog, Inc. /DE/ /s/ Robert Wicke Robert Wicke Chief Executive Officer 2022-07-21